APA (7th ed.) Citation

Xu, X., ZhENg, Z., Jia, L., Suo, S., Liu, B., Shao, T., . . . Xu, H. (2018). Overexpression of SMARCA2 or CAMK2D is associated with cisplatin resistance in human epithelial ovarian cancer. Oncology Letters, 16(3), 3796. https://doi.org/10.3892/ol.2018.9109

Chicago Style (17th ed.) Citation

Xu, Xiaoli, Zhiguo ZhENg, Lanlan Jia, Shasha Suo, BowEN Liu, Tianning Shao, Qinqing Tu, Yuejin Hua, and Hong Xu. "Overexpression of SMARCA2 or CAMK2D Is Associated with Cisplatin Resistance in Human Epithelial Ovarian Cancer." Oncology Letters 16, no. 3 (2018): 3796. https://doi.org/10.3892/ol.2018.9109.

MLA (9th ed.) Citation

Xu, Xiaoli, et al. "Overexpression of SMARCA2 or CAMK2D Is Associated with Cisplatin Resistance in Human Epithelial Ovarian Cancer." Oncology Letters, vol. 16, no. 3, 2018, p. 3796, https://doi.org/10.3892/ol.2018.9109.